MFN2 - mitofusin 2 Gene
Also Known as HSG; MARF; CMT2A; CPRP1; CMT2A2; HMSN6A; CMT2A2A; CMT2A2B
Species: Homo sapiens
About MFN2
This gene has 33 transcripts (splice variants), 201 orthologues, 1 paralogue and is associated with 11 phenotypes. Ubiquitous expression in heart (RPKM 98.6), thyroid (RPKM 37.1) and 24 other tissues.
Summary
This gene encodes a mitochondrial membrane protein that participates in mitochondrial fusion and contributes to the maintenance and operation of the mitochondrial network. This protein is involved in the regulation of vascular smooth muscle cell proliferation, and it may play a role in the pathophysiology of obesity. Mutations in this gene cause Charcot-Marie-Tooth disease type 2A2, and hereditary motor and sensory neuropathy VI, which are both disorders of the peripheral nervous system. Defects in this gene have also been associated with early-onset stroke. Two transcript variants encoding the same protein have been identified. [provided by RefSeq, Jul 2008]
MFN2 Products (2)
| mRNA | Protein | Name |
|---|---|---|
| NM_001127660.2 | NP_001121132.1 | mitofusin-2 |
| NM_014874.4 | NP_055689.1 | mitofusin-2 |
| Molecular Function GO Annotation | Evidence | References | Source |
|---|---|---|---|
| enables protein binding |
IPI
IPI: Inferred from physical interaction
|
16936636 | GOA |
| enables ubiquitin protein ligase binding |
IPI
IPI: Inferred from physical interaction
|
16936636 | GOA |
| Cellular Component GO Annotation | Evidence | References | Source |
|---|---|---|---|
| located in mitochondrion |
IDA
IDA: Inferred from direct assay
|
11181170 | GOA |
MFN2 Protein Structure
Dynamin_N: Dynamin family (99 - 258)
Fzo_mitofusin: fzo-like conserved region (586 - 755)
- 0
- 200
- 400
- 600
- 757 a.a.
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
mitofusin-2 |
|
MFN2 Protein-protein interaction Information
|
Type
|
Protein Name | Protein ID | Interactor | Interactor Species | Interactor ID | Detection Method | References |
|---|---|---|---|---|---|---|---|
|
Intra
|
MFN2 | O95140 | MFN1 | Homo sapiens | Q8IWA4 | 35271311 | |
|
Intra
|
MFN2 | O95140 | MARCHF5 | Homo sapiens | Q9NX47 | 16936636 | |
|
Intra
|
MFN2 | O95140 | LRRK2 | Homo sapiens | Q5S007 | 24282027 | |
|
Intra
|
MFN2 | O95140 | LRRK2 | Homo sapiens | Q5S007 | 24282027 | |
|
Intra
|
MFN2 | O95140 | PRKN | Homo sapiens | O60260 | 23620051 | |
|
Intra
|
MFN2 | O95140 | PRKN | Homo sapiens | O60260 | 23620051 |
MFN2 Antibodies
| Cat. No. | 상품명 | 신청 | Reactivity |
|---|---|---|---|
| HY-P80752 | Mitofusin-2 Antibody | WB, IHC-P, ELISA | Human, Mouse, Rat |
| HY-P86335 | Mitofusin-2 Antibody (YA6027) | WB, IHC-P, ICC/IF, IP, ELISA | Human, Mouse, Rat |
Related Diseases
| Diseases | Alias | |
|---|---|---|
| Neuropathy, Hereditary Motor And Sensory, Type Via, With Optic Atrophy |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Autosomal Dominant, Type 2a2a |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Autosomal Recessive, Type 2a2b |
|
|
| Charcot-Marie-Tooth Disease Type 2a2b |
|
|
| Axonal Neuropathy |
|
|
| Charcot-Marie-Tooth Disease Type 2a2a |
|
|
| Lipomatosis, Multiple Symmetric |
|
|
| Hereditary Motor And Sensory Neuropathy V |
|
|
| Peripheral Nervous System Disease |
|
|
| Hyperpigmentation Of The Skin |
|
|
| Charcot-Marie-Tooth Disease |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2e |
|
|
| Beckwith-Wiedemann Syndrome |
|
|
| Microcephaly |
|
|
| Tooth Disease |
|
|
| Genetic Motor Neuron Disease |
|
|
| Neuropathy |
|
|
| Autosomal Dominant Optic Atrophy Plus Syndrome |
|
|
| 3-Methylglutaconic Aciduria, Type Iii |
|
|
| Sensory Peripheral Neuropathy |
|
|
| Cerebral Palsy |
|
|
| Lipomatosis |
|
|
| Motor Peripheral Neuropathy |
|
|
| Charcot-Marie-Tooth Disease And Deafness |
|
|
| Aceruloplasminemia |
|
|
| Neuropathy, Congenital Hypomyelinating, 1, Autosomal Recessive |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2a1 |
|
|
| Charcot-Marie-Tooth Disease, Type 4a |
|
|
| Cranial Nerve Disease |
|
|
| Hereditary Motor And Sensory Neuropathy, Type Iic |
|
|
| Charcot-Marie-Tooth Disease, Dominant Intermediate D |
|
|
| Charcot-Marie-Tooth Disease, Demyelinating, Type 1a |
|
|
| Charcot-Marie-Tooth Disease, Demyelinating, Type 1b |
|
|
| Neuropathy, Hereditary, With Liability To Pressure Palsies |
|
|
| Hereditary Neuropathies |
|
|
| Charcot-Marie-Tooth Disease, Recessive Intermediate A |
|
|
| Charcot-Marie-Tooth Disease, X-Linked Dominant, 1 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2f |
|
|
| Neuronopathy, Distal Hereditary Motor, Type Va |
|
|
| Optic Atrophy 11 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2i |
|
|
| Charcot-Marie-Tooth Disease Type X |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2b2 |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2l |
|
|
| Optic Atrophy 3, Autosomal Dominant |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2d |
|
|
| Charcot-Marie-Tooth Disease, Type 4c |
|
|
| Gonadal Dysgenesis |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2n |
|
|
| Optic Nerve Disease |
|
|
| Hypertrophic Neuropathy Of Dejerine-Sottas |
|
|
| Pelvic Organ Prolapse |
|
|
| Kearns-Sayre Syndrome |
|
|
| Neuromyotonia And Axonal Neuropathy, Autosomal Recessive |
|
|
| Toxic Optic Neuropathy |
|
|
| Optic Atrophy 10 With Or Without Ataxia, Mental Retardation, And Seizures |
|
|
| Behr Syndrome |
|
|
| Asymmetric Motor Neuropathy |
|
|
| Diffuse Lipomatosis |
|
|
| Charcot-Marie-Tooth Disease, Axonal, Type 2b |
|
|
| Charcot-Marie-Tooth Disease Intermediate Type |
|
|
| Friedreich Ataxia |
|
|
| Neuropathy, Hereditary Sensory And Autonomic, Type Iia |
|
|
| Neuromuscular Disease |
|
|
| Pontocerebellar Hypoplasia, Type 1e |
|
|
| Leber Hereditary Optic Neuropathy, Modifier Of |
|
|
| Charcot-Marie-Tooth Disease, Type 4b2 |
|
|
| Sensory Ataxic Neuropathy, Dysarthria, And Ophthalmoparesis |
|
|
| Mitochondrial Dna Depletion Syndrome 7 |
|
|
| Mitochondrial Myopathy |
|
|
| Parkinson Disease, Late-Onset |
|
|
| Mitochondrial Dna Depletion Syndrome |
|
|
| Body Mass Index Quantitative Trait Locus 11 |
|
|
| Myoclonic Epilepsy Associated With Ragged-Red Fibers |
|
|
| Mitochondrial Dna Depletion Syndrome 4a |
|
|
| Mitochondrial Encephalomyopathy |
|
|
| Hereditary Spastic Paraplegia |
|
|
| Diabetes Mellitus |
|
|
| Hereditary Sensory And Autonomic Neuropathy Type 1 |
|
|
| Mitochondrial Myopathy, Encephalopathy, Lactic Acidosis, And Stroke-Like Episodes |
|
|
| Leigh Syndrome |
|
|
| Dilated Cardiomyopathy |
|
|
| Amyotrophic Lateral Sclerosis 1 |
|
|
| Nervous System Disease |
|
|
| Retinitis Pigmentosa |
|
|
Orthologs Information
| Species | Symbol | Source | ID |
|---|---|---|---|
| Bos taurus | MFN2 | VGNC | VGNC:31428 |
| Felis catus | MFN2 | VGNC | VGNC:63472 |
| Rattus norvegicus | MFN2 | RGD | RGD:628843 |
| Macaca mulatta | MFN2 | VGNC | VGNC:74522 |
| Mus musculus | MFN2 | MGD | MGI:2442230 |
| Canis familiaris | MFN2 | VGNC | VGNC:43193 |
| Others | MFN2 | NCBI |